Single Angio-Seal vascular closure device for transfemoral access exceeding 8F.

CONCLUSIONS: In selected cases, without availability of appropriate VCDs, a single Angio-SealTM-VIP 8F served as a feasible option to achieve sufficient hemostasis of transfemoral access exceeding 8F without relevant bleeding complications. Very low BMI, tall body-height, and severe atherosclerosis were identified to predispose to access site complications.
PMID: 32402666 [PubMed - as supplied by publisher]

Source: Journal of Cardiology - May 9, 2020 Category: Cardiology Authors: Frenzel F, Fries P, Shayesteh-Kheslat R, Buecker A, Massmann A Tags: J Cardiol Source Type: research